Table 1 |
||||
| Comparison of cases with endometrioid carcinoma and proliferative endometrium | ||||
| IHS score | Endometrioid | Proliferative | Pvalue | |
| carcinoma | endometrium | |||
| (n = 47) | (n = 10) | |||
| Fascin | 0 | 13 (27.7%) | 7 (70.0%) | p = 0.023 |
| ≤10 | 27 (57.4%) | 3 (30.0%) | ||
| ≥11 | 7 (14.2%) | 0 (0%) | ||
| CD44v6 | 0 | 25 (53.2%) | 6 (60.0%) | p = 0.542 |
| ≤10 | 19 (40.4%) | 4 (40%) | ||
| ≥11 | 3 (6.4%) | 0 (0%) | ||
IHS: immunohistochemical score.
Gun et al. Diagnostic Pathology 2012 7:80 doi:10.1186/1746-1596-7-80
